# A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents

> **NCT00447278** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 399 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Atomoxetine
- **DRUG:** Other standard therapy for ADHD

## Key facts

- **NCT ID:** NCT00447278
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2009-03
- **Final completion:** 2009-07
- **Target enrollment:** 399 (ACTUAL)
- **Last updated:** 2010-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00447278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00447278, "A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00447278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*